Cytomegalovirus Hemorrhagic Cystitis in a Malignant Glioma Patient Treated with Temozolomide

Temozolomide, a key drug in the treatment of malignant glioma, can cause profound lymphopenia and various opportunistic infectious diseases. A 79-year-old woman with anaplastic oligodendroglioma developed a fever and gross hematuria after 8 weeks of standard radiotherapy with concomitant temozolomid...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal Medicine 2018/10/15, Vol.57(20), pp.3047-3050
Hauptverfasser:	Furukawa, Ryutaro, Homma, Hirokuni, Inoue, Tomohiro, Horiuchi, Hajime, Usui, Kazuhiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antigenemia Antineoplastic Agents, Alkylating - adverse effects Antineoplastic Agents, Alkylating - therapeutic use Antiviral Agents - therapeutic use Brain cancer Case Report Cystitis Cystitis - chemically induced Cystitis - drug therapy Cytology Cytomegalovirus Cytomegalovirus Infections - chemically induced Cytomegalovirus Infections - drug therapy Female Fever Ganciclovir Glioma Glioma - drug therapy Hematuria Hemorrhage Hemorrhagic cystitis Humans Infectious diseases Internal medicine Leukocytes Lymphopenia malignant glioma Oligodendroglioma Opportunistic Infections - chemically induced Opportunistic Infections - drug therapy Pp65 protein Radiation therapy Temozolomide Temozolomide - adverse effects Temozolomide - therapeutic use Treatment Outcome Urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!